Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis
Kimberley Allen‐Philbey, Andrea Stennett, Tazkira Begum, A.B. Johnson, Ruth Dobson, Gavin Giovannoni, Sharmilee Gnanapavan, Mónica Marta, Ide Smets, Benjamin Turner, David Baker, Joela Mathews, Klaus Schmierer
Topics & Concepts
MedicineVaccinationMultiple sclerosisAdverse effectPopulationPediatricsCoronavirus disease 2019 (COVID-19)Internal medicineDiseaseImmunologyInfectious disease (medical specialty)Environmental healthMultiple Sclerosis Research StudiesSARS-CoV-2 and COVID-19 ResearchPeripheral Neuropathies and Disorders